Jiang Q, Zhong Q, Zhang Q, Zheng S, Wang G: Boron-based 4-Hydroxytamoxifen bioisosteres for treatment of de Novo Tamoxifen resistant breast cancer. ACS Med Chem Lett. 2012, 3: 392-396. 10.1021/ml3000287.
Article
CAS
PubMed
PubMed Central
Google Scholar
Harvey JM, Clark GM, Osborne CK, Allred DC: Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol. 1999, 17: 1474-1484.
CAS
PubMed
Google Scholar
Musgrove EA, Sutherland RL: Biological determinants of endocrine resistance in breast cancer. Nat Rev Cancer. 2009, 9: 631-643. 10.1038/nrc2713.
Article
CAS
PubMed
Google Scholar
Early Breast Cancer Trialists’ Collaborative Group: Tamoxifen for early breast cancer: an overview of the randomized trials. Lancet. 1998, 351: 1451-1467.
Article
Google Scholar
White I: Tamoxifen: is it safe? Comparison of activation and detoxication mechanisms in rodents and in humans. Curr Drug Metab. 2003, 4: 223-239. 10.2174/1389200033489451.
Article
CAS
PubMed
Google Scholar
Omoti AE, Omoti CE: Ocular toxicity of systemic anticancer chemotherapy. Pharm Pract. 2006, 4: 55-59.
Google Scholar
Mizutani A, Okada T, Shibutani S, Sonoda E, Helfrid H, Nishigori C, Miyachi YB, Takeda SA, Yamazoe MA: Extensive chromosomal breaks are induced by tamoxifen and estrogen in DNA repair-deficient cells. Cancer Res. 2004, 64: 3144-3147. 10.1158/0008-5472.CAN-03-3489.
Article
CAS
PubMed
Google Scholar
Carthew P, Lee PN, Edwards RE, Heydon RT, Nolan BM, Martin EA: Cumulative exposure to tamoxifen: DNA adducts and liver cancer in the rat. Arch Toxicol. 2001, 75: 375-380. 10.1007/s002040100244.
Article
CAS
PubMed
Google Scholar
Wozniak K, Kolacinska A, Blasinska-Morawiec M, Morawiec-Bajda A, Morawiec Z, Zadrozny M, Blasiak J: The DNA-damaging potential of tamoxifen in breast cancer and normal cells. Arch Toxicol. 2007, 81: 519-527. 10.1007/s00204-007-0188-3.
Article
CAS
PubMed
Google Scholar
Hoskins JM, Carey LA, McLeod HL: CYP2D6 and tamoxifen: DNA matters in breast cancer. Nat Rev Cancer. 2009, 9: 576-586. 10.1038/nrc2683.
Article
CAS
PubMed
Google Scholar
Gheldof N, Engeseth NJ: Antioxidant capacity of honeys from various floral sources based on the determination of oxygen radical absorbance capacity and inhibition of in vivo lipoprotein oxidation in human serum samples. J Agric Food Chem. 2002, 50: 3050-3055. 10.1021/jf0114637.
Article
CAS
PubMed
Google Scholar
Manyi-Loh CE, Clarke AM, Ndip RN: An overview of honey: Therapeutic properties and contribution in nutrition and human health. Afr J Microbiol Res. 2011, 5: 844-852.
Google Scholar
Swellam T, Miyanaga N, Onozawa M, Hattori K, Kwai K, Shimazui T, Akaza H: Antineoplastic activity of honey in an experimental bladder cancer implantation model: in vivo and in vitro studies. Int J Urol. 2003, 10: 213-219. 10.1046/j.0919-8172.2003.00602.x.
Article
CAS
PubMed
Google Scholar
Fukuda M, Kobayashi K, Hirono Y, Miyagawa M, Ishida T, Ejiogu EC, Sawai M, Pinkerton KE, Takeuchi M: Jungle honey enhances immune function and antitumor activity. Evid Based Complement Altern Med. 2011, 2011: 8-
Article
Google Scholar
Fernandez-Cabezudo MJ, El-Kharrag R, Torab F, Bashir G, George JA, El-Taji H, Al-Ramadi BK: Intravenous administration of manuka honey inhibits tumor growth and improves host survival when used in combination with chemotherapy in a melanoma mouse model. PLoS One. 2013, 8: e55993-10.1371/journal.pone.0055993.
Article
CAS
PubMed
PubMed Central
Google Scholar
Fauzi AN, Norazmi MN, Yaacob NS: Tualang honey induces apoptosis and disrupts the mitochondrial membrane potential of human breast and cervical cancer cell lines. Food Chem Toxicol. 2011, 49: 871-878. 10.1016/j.fct.2010.12.010.
Article
CAS
PubMed
Google Scholar
Yaacob NS, Fauzi AN, Norazmi MN: Tualang honey promotes apoptotic cell death induced by tamoxifen in human breast cancer cell lines. Evid Based Complement Altern Med. 2013, 2013: 989841-
Article
Google Scholar
Ghashm AA, Othman NH, Khattak MN, Ismail NM, Saini R: Antiproliferative effect of Tualang honey on oral squamous cell carcinoma and osteosarcoma cell lines. BMC Complement Altern Med. 2010, 10: 1-8. 10.1186/1472-6882-10-1.
Article
Google Scholar
Kadir EA, Sulaiman SA, Yahya NK, Othman NH: Inhibitory effects of Tualang Honey on experimental breast cancer in rats: a preliminary study. Asian Pac J Cancer Prev. 2013, 14: 2249-2254. 10.7314/APJCP.2013.14.4.2249.
Article
PubMed
Google Scholar
Mohamed M, Sirajudeen KNS, Swamy M, Yaacob NS, Sulaiman SA: Studies on the antioxidant properties of Tualang honey of Malaysia. Afr J Tradit Complement Altern Med. 2010, 7: 59-63. 10.1625/jcam.7.59.
Google Scholar
Bush NJ: Advances in hormonal therapy for breast cancer. Semin Oncol Nurs. 2007, 23: 46-54. 10.1016/j.soncn.2006.11.008.
Article
PubMed
Google Scholar
Brown K: Is tamoxifen a genotoxic carcinogen in women?. Mutagenesis. 2009, 24: 391-404. 10.1093/mutage/gep022.
Article
CAS
PubMed
Google Scholar
McLuckie KIE, Routledge MN, Brown K, Gaskell M, Farmer PB, Roberts GCK, Martin EA: DNA adducts formed from 4-hydroxytamoxifen are more mutagenic than those formed by α-acetoxytamoxifen in a shuttle vector target gene replicated in human Ad293 cells. Biochemistry. 2002, 41: 8899-8906. 10.1021/bi025575i.
Article
CAS
PubMed
Google Scholar
Kim SY, Suzuki N, Laxmi YR, Shibutani S: Genotoxic mechanism of tamoxifen in developing endometrial cancer. Drug Metab Rev. 2004, 36: 199-218. 10.1081/DMR-120033997.
Article
CAS
PubMed
Google Scholar
Bollig A, Xu L, Thakur A, Wu J, Kuo TH, Liao JD: Regulation of intracellular calcium release and PP1alpha in a mechanism for 4-hydroxytamoxifen-induced cytotoxicity. Mol Cell Biochem. 2007, 305: 45-54. 10.1007/s11010-007-9526-2.
Article
CAS
PubMed
Google Scholar
Duan L, Motchoulski N, Danzer B, Davidovich I, Shariat-Madar Z, Levenson VV: Prolylcarboxypeptidase regulates proliferation, autophagy, and resistance to 4-hydroxytamoxifen-induced cytotoxicity in estrogen receptor-positive breast cancer cells. J Biol Chem. 2011, 286: 2864-2876. 10.1074/jbc.M110.143271.
Article
CAS
PubMed
Google Scholar
Petinari L, Kohn LK, Carvalho JE, Genari SC: Cytotoxicity of tamoxifen in normal and tumoral cell lines and its ability to induce cellular transformation in vitro. Cell Biol Int. 2004, 28: 531-539. 10.1016/j.cellbi.2004.04.008.
Article
CAS
PubMed
Google Scholar
Liang Y, Lin S-Y, Brunicardi FC, Goss J, Li K: DNA damage response pathways in tumor suppression and cancer treatment. World J Surg. 2009, 33: 661-666. 10.1007/s00268-008-9840-1.
Article
PubMed
Google Scholar
Thomas CG, Strom A, Lindberg K, Gustafsson JA: Estrogen receptor beta decreases survival of p53-defective cancer cells after DNA damage by impairing G2/M checkpoint signaling. Breast Cancer Res Treat. 2011, 127: 417-427. 10.1007/s10549-010-1011-z.
Article
CAS
PubMed
Google Scholar
Ellsworth DL, Ellsworth RE, Liebman MN, Hooke JA, Shriver CD: Genomic instability in histologically normal breast tissues: implications for carcinogenesis. Lancet Oncol. 2004, 5: 753-758. 10.1016/S1470-2045(04)01653-5.
Article
CAS
PubMed
Google Scholar
Khanna KK, Jackson SP: DNA double-strand breaks: signaling, repair and the cancer connection. Nat Genet. 2001, 27: 247-254. 10.1038/85798.
Article
CAS
PubMed
Google Scholar
Li H, Vogel H, Holcomb VB, Gu Y, Hasty P: Deletion of Ku70, Ku80, or both causes early aging without substantially increased cancer. Mol Cell Biol. 2007, 27: 8205-8214. 10.1128/MCB.00785-07.
Article
CAS
PubMed
PubMed Central
Google Scholar
Maacke H, Opitz S, Jost K, Hamdorf W, Henning W, Krüger S, Feller AC, Lopens A, Diedrich K, Schwinger E, Stürzbecher HW: Over-expression of wild-type Rad51 correlates with histological grading of invasive ductal breast cancer. Int J Cancer. 2000, 88: 907-913. 10.1002/1097-0215(20001215)88:6<907::AID-IJC11>3.0.CO;2-4.
Article
CAS
PubMed
Google Scholar
Pucci S, Mazzarelli P, Rabitti C, Giai M, Gallucci M, Flammia G, Alcini A, Altomare V, Fazio VM: Tumor specific modulation of KU70/80 DNA binding activity in breast and bladder human tumor biopsies. Oncogene. 2001, 20: 739-747. 10.1038/sj.onc.1204148.
Article
CAS
PubMed
Google Scholar
Ahmad I, Jimenez H, Yaacob NS, Yusuf N: Tualang Honey protects keratinocytes from ultraviolet radiation-induced inflammation and DNA damage. Photochem Photobiol. 2012, 88: 1198-1204. 10.1111/j.1751-1097.2012.01100.x.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lee YS, Kang YS, Lee SH, Kim JA: Role of NAD(P)H oxidase in the tamoxifen-induced generation of reactive oxygen species and apoptosis in HepG2 human hepatoblastoma cells. Cell Death Differ. 2000, 7: 925-932. 10.1038/sj.cdd.4400717.
Article
CAS
PubMed
Google Scholar
Beretta G, Orioli M, Maffei Facino R: Antioxidant and radical scavenging activity of honey in endothelial cell cultures (EA.hy926). Planta Med. 2007, 73: 1182-1189. 10.1055/s-2007-981598.
Article
CAS
PubMed
Google Scholar